PARVOVIRUS FORMULATION

European patent · EP3277299 · In force

Register entry

Publication number
EP3277299
Application number
EP16725045
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 3, 2016
Published
Feb 7, 2018
Granted
Sep 26, 2018
Protection ends at the latest
May 2, 2036
Next annual fee due
May 31, 2027
IPC classes
A61K 35/768 (2015.01)
A61K 47/24 (2006.01)
A61K 9/00 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 15173308 23.06.2015
PCT application
PCT/EP2016/059832 03.05.2016
PCT publication
WO2016/206844 29.12.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 19, 2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 19.10.2026

  2. Jun 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.05.2025 → 31.05.2026

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Dec 12, 2018

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 12.12.2018

  6. Sep 26, 2018

    Granted

    Published in Swissreg on 26.09.2018

Parties

Inventor

KREBS, Ottheinz

81377 München, DE

ROMMELAERE, Jean

69118 Heidelberg, DE

GELETNEKY, Karsten

69121 Heidelberg, DE

LEUCHS, Barbara

69121 Heidelberg, DE

DAHM, Michael

81677 München, DE

DINSART, Christiane

68526 Ladenburg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.